The need to deliver as little radiation as possible to patients was evident during a scientific session on CT imaging of the urinary tract. Researchers presented studies that ranged in dose from 20 mAs to 200 mAs.
The need to deliver as little radiation as possible to patients was evident during a scientific session on CT imaging of the urinary tract. Researchers presented studies that ranged in dose from 20 mAs to 200 mAs.
Dr. Ulrike G. Mueller-Lisse and colleagues from the University of Munich posited that CT urography as an add-on to contrast-enhanced CT of the abdomen and pelvis may replace excretory urography in patients with pelvic tumors. But radiation exposure is a concern, so the researchers retrospectively compared upper urinary tract delineation in low-dose and routine CT urography.
Fourteen patients (116 upper urinary tract segments) received routine CT urography (120 kVp, pitch 0.875, 175 mAs), while 26 patients (344 upper urinary tract segments) received the low-dose protocol (29 mAs, other parameters unchanged). The scanner was a four-slice machine.
Delineation of the upper urinary tract was equally good for all segments in routine and low-dose CT urography, said coauthor Dr. Eva M. Coppenrath. The intrarenal collecting system and upper and middle ureter were clearly delineated as often on both protocols. Image quality of the lower ureter suffered with low-dose CT, however.
Coppenrath concluded that low-dose CT urography was sufficient to determine the course of the upper urinary tract and perhaps locate obstruction and dilation, but it would have been unlikely to locate intraluminal lower ureter lesions.
Dr. Eike Hein and colleagues from Charite Hospital in Berlin found that an ultralow-dose CT protocol-with a radiation dose comparable to a conventional abdominal survey (KUB)-can reliably detect urolithiasis.
Researchers in the Berlin study prospectively examined 104 patients suspected of having renal colic. Sixteen-slice CT parameters included 120 kVp, 20 mAs, and pitch 23. All patients also received an ultrasound.
The mean effective whole-body dose of the CT scan was 0.5 mSv in men and 0.7 mSv in women. These values are fairly equivalent to the dose of KUB (0.5 to 0.9 mSv), Hein said. The incidence of renal calculi detected by CT was 69% in all cases, 78% in the presence of hematuria, and 54% without hematuria. All renal calculi identified by ultrasound were detected on CT.
"Significantly more ureteral calculi were identified on CT than on ultrasound, whereas there was no significant difference in the diagnosis of renal calculi or urinary tract dilatation," Hein said.
The overall sensitivity for low-dose CT was 97% compared with 63% for ultrasound. Coronal views are suitable for quickly determining the size and location of calculi, she said. Radiologists' subjective diagnostic confidence in interpreting the ultralow-dose CT scans was 80% for detecting calculi and 91% for diagnosing of urinary tract dilatation.
Seven Takeaways from Meta-Analysis of PSMA Radiotracers for Prostate Cancer Imaging
December 1st 2023In a newly published meta-analysis of 24 studies, researchers noted that the PSMA PET radiotracer 18F PSMA-1007 may provide more benefit than 68Ga Ga-PSMA-11 for primary staging of patients with prostate cancer and detection of local lesion recurrence, but also has drawbacks with higher liver uptake and multiple reports of false positive bone lesions.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.